There's something Jim Cramer keeps repeating on Mad Money that actually makes sense if you think about it - the stocks everyone's chasing in parabolic moves tend to be the ones that hurt you the most when sentiment flips. He's been pretty vocal about this lately, especially when it comes to the hot tech and AI names that keep getting pumped.

Cramer's take is straightforward: he loses money when he tries to ride those waves. So instead of fighting the market like some retail trader, he's doing the opposite. While everyone's obsessed with Intel and AMD, Jim Cramer is quietly picking up quality companies that have gotten absolutely destroyed and fallen completely out of favor. It's the contrarian play, but with fundamentals backing it.

The perfect example right now is Johnson & Johnson. His investment club just loaded up on JNJ while the stock was still getting beaten down. Healthcare has been the worst-performing sector in the S&P 500 this year, which honestly makes it interesting from a value perspective. JNJ specifically has been dealing with noise around litigation concerns, but underneath all that noise, there's real stuff happening - the company's been reshaping itself, spinning off slower divisions, and loading up on late-stage drug development.

What's wild is that Jim Cramer now considers JNJ his top pick in pharma, above Eli Lilly. The pipeline is solid, and the business transformation is actually working if you look past the headlines. The recent weakness has been mostly emotional rather than fundamental.

But here's the bigger lesson Jim Cramer keeps emphasizing about portfolio construction - you can't just own the hot names. That's how you get destroyed when rotation happens. If you've got some beaten-down quality names mixed in with your winners, at least you've got something that still works when the market's mood changes. It's diversification done right, not just owning 10 different hot stocks.

This is apparently a lesson he picked up during his Goldman Sachs days, and it's held up pretty well. The healthcare sector getting hammered just means there are opportunities if you're willing to look where everyone else is avoiding. That's the Jim Cramer contrarian thesis in a nutshell - quality over momentum, always.